Cyclooxygenase as a target in lung cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Joanne R Brown, Raymond N DuBois

Abstract

Preclinical studies suggest that cyclooxygenase (COX)-2 may be involved in the molecular pathogenesis of some types of lung cancer. Most of the available studies point to its involvement in non-small cell lung cancer. Survival of patients with non-small cell lung cancer expressing high levels of COX-2 is markedly reduced. Treatment of humans with the selective COX-2 inhibitor celecoxib augments the antitumor effects of chemotherapy in patients with non-small cell lung cancer. COX-2 has been shown to regulate some aspects of tumor-associated angiogenesis. Most of the results we have published point to effects on the regulation of vascular endothelial growth factor. However, prostaglandins derived from COX-2 affect other signaling pathways as well, such as the epidermal growth factor and its receptor. Others have recently shown that non-small cell lung cancer exhibits a COX-2 downstream enzyme expression pattern that is altered in lung tumor cells and tumor-supplying vessels. Therefore, COX-2 and prostaglandins may have a major impact on lung tumor progression and tumor-associated inflammation. Clinical trials currently underway are exploring the potential of targeting COX-2 in lung cancer.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Mar 1, 1994·Epidemiology·D M Schreinemachers, R B Everson
Aug 6, 1998·The Journal of Clinical Investigation·D A ArenbergR M Strieter
Oct 6, 1999·The Annals of Thoracic Surgery·Y OhtaY Watanabe
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·M StolinaS M Dubinett
Jun 7, 2000·The Journal of Clinical Investigation·C S WilliamsR N DuBois
Oct 18, 2000·Current Medicinal Chemistry·K M LeahyJ L Masferrer
Nov 22, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y HosomiA Ochiai
Apr 26, 2001·The Journal of Biological Chemistry·M DohadwalaS M Dubinett
Mar 8, 2002·Annals of Surgery·Jan BrabenderPeter V Danenberg
Mar 20, 2002·Nature Reviews. Cancer·R A Gupta, R N Dubois
Apr 12, 2002·Current Pharmaceutical Design·William F AndersonErnest T Hawk
Nov 28, 2002·BMC Cancer·Kirsten B MoysichGerold Bepler
Mar 14, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H Y FangL-S Wang
Apr 1, 2003·Advances in Experimental Medicine and Biology·Alane KokiJaime L Masferrer
Jun 11, 2003·Progress in Experimental Tumor Research·Steven M DubinettJenny T Mao

❮ Previous
Next ❯

Citations

Aug 28, 2012·Cancer Immunology, Immunotherapy : CII·Katja HattarUlrich Grandel
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Vladislava O MelnikovaMenashe Bar-Eli
Sep 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Florian HohlaCelia A Kanashiro
Dec 23, 2006·American Journal of Respiratory and Critical Care Medicine·Tanyalak ParimonDavid H Au
Jul 29, 2006·American Journal of Respiratory Cell and Molecular Biology·Seddigheh Razani-Boroujerdi, Mohan L Sopori
Feb 22, 2008·Neuro-oncology·Stuart A GrossmanUNKNOWN New Approaches to Brain Tumor Therapy CNS Consortium
Nov 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Florian HohlaGabor Halmos
Mar 29, 2014·Cancer Cell International·Xing WuLie-Ming Lou
Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M Pérez-Moreno
Aug 28, 2007·Cancer Metastasis Reviews·Vladislava Melnikova, Menashe Bar-Eli
Jan 27, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Isaac SipoHenry Fechner
Sep 10, 2008·Current Oncology Reports·Ranjit K Goudar, Gordana Vlahovic
Aug 19, 2006·Immunological Investigations·Carolyn J BagloleRichard P Phipps
Mar 5, 2015·International Journal of Molecular Medicine·Laizang WangWu Yue
Feb 9, 2016·Seminars in Cancer Biology·Nagendra Sastry YarlaGovinda Rao Duddukuri
Dec 6, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Bryan J SchneiderShirish M Gadgeel
Dec 25, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Paul J LimburgUNKNOWN Cancer Prevention Network
May 1, 2010·Chemico-biological Interactions·Kristen P NickensSusan Ceryak
Apr 14, 2009·Clinical Lung Cancer·Michel M Van den HeuvelNico van Zandwijk
Dec 27, 2008·Toxicology and Applied Pharmacology·Laura M BeaverSteven R Patierno
May 24, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ryujiro SuzukiKaoru Shimokata
Nov 10, 2015·European Journal of Pharmacology·Rui LiuGui-Shan Tan
Oct 24, 2007·The Journal of Surgical Research·Reid C VegelerC Max Schmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.